Published Date: 16 Feb 2023
As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?
Read Full NewsTelemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.
A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.
3.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
4.
In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.
5.
Best foot forward—chemo care should include podiatry, say researchers
1.
Everything You Need to Know About the Latest Hyponatremia Algorithm
2.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
3.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
4.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
5.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation